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Modulation of renal epithelial barrier function by mitogen- A defining characteristic of epithelial cells is their abil-
activated protein kinases (MAPKs): Mechanism of cyclospo- ity to function as barriers between compartments in the
rine A–induced increase in transepithelial resistance. body. They do this by acting as asymmetric transportersBackground. Cyclosporine A (CsA) has been shown to in-
of salt, nonelectrolytes and water, thereby influencingcrease transepithelial resistance in Madin-Darby canine kidney
the volume and composition of the compartments they(MDCK) cells, and the mechanism may involve altered phos-
phorylation of junctional proteins. In this study, we examine define. The epithelial cells lining the nephron are crucial
the effect of the extracellular signal-regulated protein kinase to the vectorial transport of solutes and water along its
(ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK)
length and, therefore, the maintenance of overall bodypathways on the basal transepithelial resistance (TER) and on
homeostasis. The tightness of the epithelium is determinedthe CsA-induced increase in TER across MDCK monolayers.
Here we present evidence that CsA may be mediating some of by intercellular junctions, in particular the tight junction,
its effects through activation of the ERK 1/2 MAPK pathway. which regulates the passage of ions and small molecules
Methods. MDCK cells were treated with CsA (4.2 mol/L) through the paracellular pathway. Tight junctions are sub-and paracellular permeability was assessed by measuring TER.
ject to physiologic regulation and also undergo dynamicThe role of the ERK 1/2 and the p38 MAPK pathways in
modulation by agents as diverse as cytokines [1, 2], cal-modulating TER was investigated using the inhibitors PD98059
and U0126 for ERK 1/2 and SB203580 for p38. ERK 1/2 and cium [3, 4], phorbol esters [5, 6], adenosine triphosphate
p38 phosphorylation/activation was also examined by Western (ATP) [7, 8], bacterial toxins [9], and fatty acids [10].
blot analysis. Cyclosporine A (CsA) is an immunosuppressive agentResults. CsA (4.2 mol/L) increased the TER of MDCK
that has revolutionised organ transplantation. However,monolayers. The ERK 1/2 inhibitor PD98059 decreased basal
TER and also ameliorated the CsA-induced increase in TER. a major limitation to the clinical use of CsA is nephrotox-
Similar results were found with the U0126 inhibitor of ERK icity [11]. Mechanisms of CsA-induced nephrotoxicity
1/2. The p38 inhibitor SB203580 had no effect on the basal TER were previously thought to be hemodynamic in origin,
of the monolayers, however, SB203580 significantly augmented
but there is accumulating evidence for a direct tubularthe CsA-induced increase in TER. CsA was shown to signifi-
effect. CsA-induced tubular damage is not well under-cantly activate ERK 1/2 and this activation by CsA was pre-
vented by PD98059. Inhibition of the p38 pathway by SB203580 stood. However, alterations in proximal tubular mor-
also resulted in activation of ERK 1/2 and this activation of phology have been seen in acute studies in rats [12–14].
ERK 1/2 was further enhanced by CsA. No effect of CsA or Renal cells in culture provide an in vitro model systemthe inhibitors PD98059 or SB203580 on p38 phosphorylation
to explore potential mechanisms of CsA-induced nephro-was detected.
toxicity. Our laboratory has previously shown that CsAConclusion. The results presented here suggest that activa-
tion of the ERK 1/2 MAPK cascade is important in the regula- has direct effects on the porcine proximal tubular cells
tion of the paracellular permeability in MDCK cells. Activation (LLC-PK1) renal cell line, a model for proximal tubularof this pathway appears to be pivotal to the CsA-induced in- cells, inducing apoptosis at low doses (nmol/L) and ne-crease in TER.
crosis at high doses (mol/L) [15]. Those studies indicate
that CsA can have direct effects on renal epithelial cells.
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Soc Nephrol 10:648A, 1999]. The CsA-induced increase tained from Calbiochem (La Jolla, CA, USA). The source
in transepithelial resistance (TER) appeared to involve and the nature of the antibodies used are described in
altered expression and/or phosphorylation of junctional the Western blot analysis Methods section. All other
proteins and was enhanced in the presence of the serine/ reagents were of the highest available purity from com-
threonine phosphatase inhibitor, okadaic acid. mercial sources.
While the current understanding of the immunosup-
Cell culturepressive action of CsA focuses on cyclophilins and inhibi-
tion of calcineurin [16], it is not known if the nephrotoxic The MDCK low resistance (approximately 100 ohms.
actions operate through similar mechanisms. Findings cm2) strain II renal cell line was utilized. The MDCK cells
from our laboratory indicate that CsA-mediated increase were of distal tubular/collecting duct origin isolated from
in transforming growth factor- (TGF-) in renal proxi- a canine kidney [30]. They were obtained from the Amer-
mal tubular LLC-PK1 cells involves activation of the ican Type Culture Collection. The cells were maintained
mitogen-activated protein kinase (MAPK) and extracel- in Dulbecco’s Modified Eagles Medium (DMEM) con-
lular signal-related protein kinase (ERK) 1/2 system taining 10% (v/v) fetal calf serum (FCS), 100 U/mL peni-
[abstract; Keane T et al, J Am Soc Nephrol 9:596A, 1998]. cillin, 100g/mL streptomycin, and 2 mmol/L glutamine.
Other reports also indicate that CsA can activate the Culture medium was changed every other day. Cells were
ERK 1/2 MAPK pathway in HeLa cells, renal epithelial grown to confluency in 75 cm2 Costar flasks and main-
BSC-1 cells and 3T3 fibroblasts [17]. tained at 37C in a humidified atmosphere containing
The MAPK family makes up a group of important 95% air and 5% CO2. When cells reached the degree of
intracellular mediators of signal transduction from the confluency required, they were trypsinised to form a
cell-surface to the nucleus in response to various stimuli single cell suspension using a trypsin/ethylenediamine-
[18, 19]. There are currently three well-characterized mam- tetraacetic acid (EDTA) mixture in DMEM. Disassoci-
malian MAPK signaling cascades. These are the classical ated cells were harvested by centrifugation at 1000 rpm
ERK 1/2 (p44/42) MAPK pathway, the c-jun N-terminal for 3 minutes in a benchtop centrifuge and seeded at an
kinases (JNKs) or SAPK MAPK pathway, and the p38 appropriate density.
MAPK pathway. The ERK 1/2 MAPK pathway has been
associated with the regulation of cellular proliferation Cell treatment
and differentiation and is activated mainly by mitogens CsA was prepared as a stock solution (4.2 mmol/L)
such as epidermal growth factor (EGF) and platelet- by dissolving the powder in 100% EtOH. PD98059,
derived growth factor (PDGF) [20]. The latter two U0126, and SB203580 were prepared as stock solutions
MAPK pathways are commonly referred to as the stress-
of 10 mmol/L in dimethyl sulfoxide (DMSO) and storedactivated MAPK pathways and are activated in response
in aliquots at20C in the dark. Cells were preincubatedto diverse stimuli such as osmotic stress, ultraviolet radia-
for 1 hour with the inhibitors PD98059 (10 mol/L),tion, and proinflammatory cytokines [21]. The role of
SB203580 (10 mol/L), or a combination of both inhibi-MAPK activation in mediating particular cellular re-
tors prior to treatment with 4.2 mol/L CsA.sponses, such as regulation of gene expression, has been
aided by the discovery of specific pharmacologic inhibi- Transepithelial electrical resistance (TER)
tors. PD98059 and U0126 are inhibitors of the ERK 1/2
The intactness of the paracellular pathway of theMAPK pathway [22] and SB203580 is an inhibitor of the
MDCK epithelial monolayers was monitored by measur-p38 MAPK pathway [23].
ing TER using the Endohm apparatus (World PrecisionThe role of the MAPK pathway in the regulation of
Instruments, New Haven, CT, USA) or REMS roboticthe paracellular pathway across epithelial cells has not
device (World Precision Instruments). When using thebeen explored extensively. However, the studies that
Endohm apparatus, cells were grown on Costar Trans-have been carried out report conflicting results for the
well-clear cell culture inserts, which consist of tissue cul-role of MAPKs in tight junction modulation [24–29].
ture–treated polyester membranes with a pore size ofIn this study, the effects of the ERK 1/2 and p38
0.4m, insert diameter of 12 mm, and an effective growthMAPK pathways on the barrier function of renal epithe-
area of 1 cm2. The upper chamber (apical side) containedlial MDCK cells were assessed. The role of the MAPK
0.5 mL medium and the lower one (basolateral side)pathways in the CsA-induced modulation of barrier func-
contained 1.8 mL medium. When using the REMS ro-tion was also investigated.
botic device, cells were grown on Costar HTS-Transwell
cell culture inserts, which consist of tissue culture–
METHODS treated polycarbonate membranes with a pore size of
Materials 0.4 m, insert diameter of 6.5 mm, and an effective
growth area of 0.33 cm2. The upper chamber (apical side)CsA was a generous gift from Novartis Pharmaceuti-
cals, Ltd., UK. PD98059, U0126, and SB20350 were ob- contained 0.25 mL medium and the lower one (basolat-
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the filters. The cells were immediately scraped from theeral side) contained 1 mL medium. MDCK cells were
filters, transferred to 1.5 mL Eppendorf tubes (Cam-seeded at a density of 1 105 cells/mL and were seen to
bridgeshire, UK), and kept on ice. Cells were sonicatedreach a stable TER representing a confluent monolayer
for 10 seconds to shear DNA and reduce sample viscos-5 days after seeding. The medium was changed every 2
ity. Samples were then heated to 100C for 5 minutes,days and the cells were incubated at 37C in 95% air and
and cooled on ice. Finally, the samples were centrifuged5% CO2. Confluent monolayers of cells were exposed
for 5 minutes at 14,000 rpm. Samples were kept at20Cto the various treatments 5 days after seeding on the
until required. Just before electrophoresis, samples wereapical and basolateral domains. The point of addition of
boiled for 5 minutes, allowed to cool, and centrifugedthe drug was taken as time zero and TER across the
at 14,000 rpm for 5 minutes.monolayers was monitored over a range of time points
(2 to 72 hours) under sterile conditions in a laminar
Sodium dodecyl sulfate-polyacrylamide gelflow hood using the Endohm apparatus or the REMS
electrophoresis (SDS-PAGE)robotic device. The TER was normalized to the area of
The procedure used was that of Laemmli [32], in whichthe filter after removal of background resistance of a
multiple protein samples were electrophoresed on a thinblank filter on which cells were not seeded and which
slab of polyacrylamide gel. Cellular lysate (20 L) wascontained only medium. TER was thus measured as
loaded per well.ohms  cm2 (.cm2). The results were expressed as the
change in TER with respect to time matched controls
Western blot analysis[TER (.cm2)].
Following electrophoresis, an unstained gel was soaked
Cellular viability determined by neutral red uptake assay in transfer buffer (48 mmol/L Tris, 39 mmol/L glycine,
20% (v/v) MeOH, and 0.037% (w/v) SDS, pH 8.3) for2-amino-3-methyl-7-dimethyl-amino-phenazonium-
5 minutes. The proteins within the gel were then trans-chloride (neutral red) uptake by cells was measured by
ferred to nitrocellulose membrane (0.2m pore size) usingthe method described by Borenfreund and Puerner [31].
a semi dry transfer system at 80 milliamps for 1 hour.The neutral red assay is based on the uptake of neutral
Staining of the blots with Ponceau stain was preformedred dye and its accumulation in the lysosomes of unin-
to ensure proper transfer of proteins. The blots werejured, viable cells. Neutral red was prepared as a 0.4%
blocked for 2 hours at room temperature with 5% (w/v)(w/v) aqueous stock solution. A fresh solution of the dye,
milk proteins/Tris-buffered saline (TBS). The blots wereyielding a final concentration of 50 g/mL, was prepared
then incubated overnight at 4C with a 1:500 dilutionin DMEM 24 hours prior to use. Cells grown on Costar
of the appropriate primary antibody in 5% (w/v) milkfilters were treated appropriately for 72 hours. The cells
proteins/TBS, with gentle agitation: rabbit antiphosphowere then washed three times with phosphate-buffered
p38 antibody, rabbit antiphospho p44/42 antibody, rabbitsaline (PBS). The basolateral surface was exposed to 1.8
anti-p38 antibody or rabbit anti-p44/42 antibody (NewmL while the apical surface was exposed to 0.5 mL of
England Biolabs, Hertfordshire, UK). The blots werethe 50 g/mL neutral red in DMEM for 3 hours at 37C.
then washed three times with Tris-buffered saline withThe cells were washed three times with PBS and then
0.1% Tween (TBST), followed by three washes withwashed rapidly with 0.5 mL of formol-calcium mixture
TBS for 10 minutes each, with vigorous agitation. After[4% (w/v) formaldehyde and 1% (w/v) anhydrous CaCl2],
washing, the blots were incubated with a 1:2000 dilutionwhich removes any unincorporated dye and also pro-
of antirabbit horseradish peroxide antibody in 5% (w/v)motes adhesion of the cells to the substratum. Dye taken
milk proteins/TBS for 30 minutes at room temperatureup into the lysosomes of viable cells was extracted by
with gentle agitation. The blots were finally washed threetreating the cells for 15 minutes at room temperature
times with TBST and three times with TBS for 5 minuteswith 0.5 mL 1% (v/v) glacial acetic acid in 50% ethanol
each, with vigorous agitation. The presence of bound anti-(EtOH). The absorbance was determined at 540 nm and
body was detected using a chemiluminescence blottingviability was expressed as a percentage of the absorbance
system with the substrate luminol (Boehringer Mann-recorded for control cells (% control viability).
heim, East Sussex, UK).
Preparation of whole cell extracts for phosphorylated
Statistical analysisand whole cell MAPK proteins
Data was analyzed by one-way ANOVA (analysis ofCells grown on Costar Transwell filters were treated
variance) and multiple comparison between treatmentappropriately for 24 hours. Cell lysates were made ac-
groups were made using the Dunnett post test. Resultscording to the “New England BIOLABS” protocol. Cells
were expressed as the mean SEM. A probability of 0.05were lysed by adding 100 L sodium dodecyl sulfate
or less was deemed statistically significant. The following(SDS) sample buffer [62.5 mmol/L Tris-HCl (pH 6.8),
scheme was used throughout. *P 	 0.05, **P 	 0.01,2% (w/v) SDS, 10% glycerol, 50 mmol/L dithiothreitol
(DTT), 0.1% w/v bromophenol blue] to the apical side of ***P 	 0.001.
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at the 48- and 72-hour time points in the MDCK cells
(Fig. 2). In addition, PD98059 showed major effects in
preventing the CsA-induced increases in TER. The
PD98059-induced prevention of the CsA-induced in-
creases in TER were significant at all time points of 24,
48, and 72 hours with effects being greatest at the longer
time points. At the 48- and 72-hour time points there
was almost complete prevention of the CsA-induced in-
crease in TER. An alternative ERK 1/2 inhibitor, U0126,
produced very similar results to that demonstrated with
PD98059. The results with U0126 are shown in Figure
3. U0126 on its own significantly reduced the TER and
also prevented the CsA-induced increase in TER. The
effects were most noticeable at the 48- and 72-hour time
points, but was also significant at the 24-hour time point.
The PD98059-induced reduction in TER on its own or
the PD98059-induced prevention of the CsA-mediated
increase in TER were not due to any gross cytotoxicity.
As demonstrated in the results presented in Figure 5,
neither PD98059 on its own or in combination with CsA
(4.2 mol/L) significantly altered the viability of MDCK
cells up to the 72-hour time period.
The p38 MAPK inhibitor SB203580 (10mol/L) on its
own had no significant effect on TER (Fig. 4). However,
SB203580 in combination with CsA (4.2 mol/L) did
significantly augment the CsA-induced increase in TER
at the 24- and 48-hour time points. These changes were
not due to any alterations in cellular viability as the
results presented in Figure 5 demonstrated that neitherFig. 1. Effect of treatment with apical cyclosporine A (CsA) (A ) or
basolateral CsA (B ) on the transepithelial electrical resistance (TER) SB203580 (10 mol/L) nor CsA (4.2 mol/L) either
across Madin-Darby canine kidney (MDCK) cell monolayers. Cells alone or in combination adversely affected cellular via-
were grown on Transwell filters and treated with 4.2 mol/L CsA from
bility.either the apical chamber or the basolateral chamber for a period of
72 hours. Results are expressed as the change in TER (TER) compared As PD98059 and SB203580 showed very significant
to time-matched control filters and are given as mean  SEM of three effects on the CsA-induced alterations in TER, we de-
independent experiments, performed in triplicate. A one-way analysis of
cided to investigate the activation/phosphorylation statusvariance (ANOVA) was carried out and multiple comparisons between
control and treatment groups were made using the Dunnett post test. of these MAPK pathways in MDCK cells following expo-
**Indicates statistically different (P 	 0.01) to control. sure to CsA, PD98059, or SB203580.
Effect of CsA and the MAPK inhibitors on the
phosphorylation (activation) of ERK 1/2 and p38 in
RESULTS MDCK cells
Effect of CsA on the TER across MDCK monolayers In MDCK cells, there was basal activity/phosphoryla-
The TER of confluent control strain II MDCK cells tion of the ERK 1/2 kinase (Fig. 6A). CsA (4.2 mol/L)
was found to be 116  2.3 ohms.cm2. Exposure of con- produced a very marked increased phosphorylation/acti-
fluent MDCK monolayers to 4.2 mol/L CsA at either vation of the ERK 1/2 at the 24-hour time point as dem-
the apical or basolateral sides induced significant in- onstrated in lane 2, Figure 6A. PD98059 (10 mol/L)
creases in TER (Fig. 1). The increases were significant did not alter the basal level (lane 3, Fig. 6A), but did
after 24 hours treatment and were maintained for 48 and reduce the CsA-mediated increase in ERK 1/2 activation
72 hours. (lane 4, Fig. 6A). SB203580 (10 mol/L) on its own
demonstrated enhanced phosphorylation of ERK 1/2
Effect of the inhibitors of the ERK 1/2 and p38 (lane 5, Fig. 6A). Furthermore, SB203580 augmented
pathways on the basal TER and on the CsA-induced the CsA-induced increase in phosphorylation of ERK
increase in TER 1/2 (lane 6, Fig. 6A). Simultaneous treatment with
The ERK 1/2 inhibitor PD98059 (10 mol/L), on its PD98059 and SB203580 markedly reduced the stimula-
tion of phosphorylation seen in the presence of SB203580own, induced statistically significant decreases in TER
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Fig. 2. Effect of PD98059 on the cyclosporine
A (CsA)–induced increase in transepithelial
electrical resistance (TER) across Madin-Darby
canine kidney (MDCK) cell monolayers. Cells
were grown to confluency on Costar Transwell
filters and treated for a period of 72 hours.
Cells were pretreated for 1 hour with 10mol/L
PD98059 ( ) and 4.2 mol/L CsA ( ), prior
to treatment with both (). Results are ex-
pressed as the change in TER (TER) com-
pared to time-matched control filters and are
given as mean  SEM of five independent
experiments, each performed in duplicate. A
one-way analysis of variance (ANOVA) was
carried out and multiple comparisons between
control and treatment groups were made using
the Dunnett post test. Multiple comparisons
between different treatments were carried out
using the Bonferroni post test. *P 	 0.05,
**P 	 0.01,*** P 	 0.001.
Fig. 3. Effect of U0126 on the cyclosporine
A (CsA)–induced increase in transepithelial
electrical resistance (TER) across Madin-Darby
canine kidney (MDCK) cell monolayers. Cells
were grown to confluency on Costar HTS-
Transwell cell culture inserts and treated for a
period of 72 hours. Cells were pretreated for 1
hour with 10mol/L U0126 ( ) and 4.2mol/L
CsA ( ), prior to treatment with both ().
TER was measured using REMS robotic sys-
tem (World Precision Instruments). Results are
expressed as the change in TER (TER) com-
pared to time-matched control filters and are
given as mean SEM of five independent ex-
periments, each performed in duplicate. A one-
way analysis of variance (ANOVA) was carried
out and multiple comparisons between control
and treatment groups were made using the
Dunnett post test. Multiple comparisons be-
tween different treatments were carried out
using the Bonferroni post test. *P 	 0.05,
**P 	 0.01, ***P 	 0.001.
alone (lane 7 compared to lane 5, Fig. 6A), suggesting findings with the various combinations of treatments
that the effect of SB203580 is mediated via the MAPK/ (lanes 1 to 8, Fig. 7A) suggest that neither CsA nor
ERK kinase (MEK) 1/2 and ERK 1/2 pathway. Likewise PD98059 affected the phosphorylation of p38. Likewise,
the effect of SB203580 in combination with CsA on phos- no major changes in whole cell p38 were detected with the
phorylation of ERK1/2 was abolished in the presence of various combinations of treatments (lanes 1 to 8, Fig. 7B).
PD98059 (lane 6 compared to lane 8 in Fig. 6A). None
of the alterations detected in phosphorylation of ERK
DISCUSSION1/2 were due to changes in whole cell ERK 1/2 as these
These findings provide further evidence that CsA canremain unchanged as demonstrated in Figure 6B.
affect barrier function of renal epithelial cells and indi-The results with phosphorylation of the p38 MAP ki-
cate that the mechanism may involve activation of thenase are shown in Figure 7. No major alterations in p38
ERK 1/2 MAPK pathway. The barrier function of the epi-phosphorylation were detected following CsA, PD98059,
or SB203580 treatment alone or in combination. These thelial monolayer was investigated by measuring the
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Fig. 4. Effect of SB203580 on the cyclosporine
A (CsA)–induced increase in transepithelial
electrical resistance (TER) across Madin-Darby
canine kidney (MDCK) cell monolayers. Cells
were grown to confluency on Costar Transwell
filters and treated for a period of 72 hours. Cells
were pretreated for 1 hour with 10 mol/L SB-
203580 ( ) and 4.2 mol/L CsA ( ), prior to
treatment with both (). Results are expressed
as the change in TER (TER) compared to
time-matched control filters and are given as
mean  SEM of five independent experi-
ments, each performed in duplicate. A one-
way analysis of variance (ANOVA) was car-
ried out and multiple comparisons between
control and treatment groups were made using
the Dunnett post test. Multiple comparisons
between different treatments were carried out
using the Bonferroni post test. **P 	 0.01,
***P 	 0.001.
These changes were highly significant given that the
starting TER was in the order of 100 .cm2. These find-
ings confirm our other studies showing that CsA can
increase TER in MDCK cells [abstract; Kiely B et al, J
Am Soc Nephrol 10:648A, 1999]. Other studies indicate
a variety of hepatic abnormalities following CsA treat-
ment may be related to barrier function alterations.
[34, 35]. Lora et al [36] demonstrated that low doses of
CsA significantly increased hepatic tight junction perme-
ability. CsA-induced increases in tight junction perme-
ability have also been demonstrated in rat hepatocyte
couplets [37].
In other studies, we found that the CsA-mediated in-
Fig. 5. Effect of PD98059 and SB203580 on cellular viability of Madin- crease in TER was associated with increased phosphory-
Darby canine kidney (MDCK) cells at 72 hours. Cells were grown
lation/expression of the tight junction protein occludin.to confluency on Costar Transwell filters and treated with vehicle di-
methylenephoxide (DMAO), 4.2 mol/L cyclosporine A (CsA), 10 Furthermore, the serine/threonine phosphatase inhibi-
mol/L PD98059 4.2mol/L CsA, 10mol/L SB203580 4.2mol/L tor, okadaic acid, augmented the CsA-induced increase
CsA for 72 hours. Cellular viability was assessed using the neutral red
in TER. This indicated that phosphorylation could playcytotoxicity assay. Results are expressed as % control and are given as
mean  SEM of three independent experiments each performed in a major role in the CsA-induced alteration of TER in
duplicate. A one-way analysis of variance (ANOVA) was carried out MDCK cells. Studies carried out in our laboratory have
and multiple comparisons between control (100% viability) and treat-
shown that CsA activates the ERK 1/2 pathway in LLC-ment groups were made using the Dunnett post test.
PK1 cells [abstract; Keane T et al, J Am Soc Nephrol
9:596A, 1998]. It has also previously been shown that
CsA activates the ERK 1/2 MAPK pathway in HeLa
TER across the cells. TER is known to be a sensitive cells, renal epithelial BSC-1 cells, and 3T3 fibroblasts
measure of the barrier function or integrity of tight junc- [17]. Therefore, the possibility that alterations in MAPK
tions with the resistance value obtained being directly pathways could be involved in the CsA-induced increase
proportional to the permeability of the tight junction in TER were explored.
to inorganic ions [33]. When confluent monolayers of Our findings that inhibition of ERK 1/2 resulted in a
MDCK cells were exposed to CsA, there was a time- significant decrease in the TER, and also significantly re-
dependent increase in TER. The mean increases in TER duced the CsA-induced increase in TER of MDCK mono-
in the MDCK cells was in the order of 20 to 100 .cm2 layers suggest that the CsA-induced increase in TER in-
volves MEK 1/ERK 1/2 signal pathways. This hypothesisdepending on conditions and time of exposure.
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Fig. 7. Western blot analysis of phosphorylated p38 (A ) and whole
Fig. 6. Western blot analysis of phosphorylated extracellular signal- cell p38 (B ) expression in Madin-Darby canine kidney (MDCK) cells
regulated kinase (ERK) 1/2 (A ) and whole cell ERK 1/2 (B ) expression following treatment with the mitogen-activated protein kinase (MAPK)
in Madin-Darby canine kidney (MDCK) cells following treatment with inhibitors PD98059 (PD) and SB203580 (SB) in the presence or absence
the MAPK inhibitors PD98059 (PD) and SB203580 (SB) in the presence of cyclosporine A (CsA). MDCK cells were grown to confluency on
or absence of cyclosporine A (CsA). MDCK cells were grown to conflu- Costar Transwell filters and treated as described for 24 hours. Cells
ency on Costar Transwell filters and treated as described for 24 hours. were pretreated for 1 hour with 10 mol/L PD98059 or 10 mol/L
Cells were pretreated for 1 hour with 10 mol/L PD98059 or 10 mol/L SB203580, either alone or in combination prior to treatment with 4.2
SB203580, either alone or in combination prior to treatment with 4.2 mol/L CsA. Whole cell lysates were then made using radioimmunopre-
mol/L CsA. Whole cell lysates were then made using radioimmunopre- cipitation (RIPA) lysis buffer. Cellular proteins were separated electro-
cipitation assay (RIPA) lysis buffer. Cellular proteins were separated phoretically on sodium dodecyl sulfate (SDS) polyacrylamide gel and
electrophoretically on sodium dodecyl sulfate (SDS) polyacrylamide transferred to nitrocellulose membrane. Expression of phospho p38
gel and transferred to nitrocellulose membrane. Expression of phospho (A) was identified using a polyclonal rabbit antiphospho p38 antibody
ERK 1/2 (A) was identified using a polyclonal rabbit antiphospho ERK and an antirabbit horseradish peroxide–conjugated secondary antibody.
1/2 antibody and an antirabbit horseradish peroxide–conjugated second- The nitrocellulose was then stripped of the antibody and expression of
ary antibody. The nitrocellulose was then stripped of the antibody and whole cell p38 (B) was identified using a polyclonal rabbit anti-p38
expression of whole cell ERK 1/2 (B) was identified using a polyclonal antibody and an antirabbit horseradish peroxide–conjugated secondary
rabbit anti-ERK 1/2 antibody and an antirabbit horseradish peroxide– antibody. Control (lane 1); 4.2 mol/L CsA (lane 2); 10 mol/L PD
conjugated secondary antibody. Control (lane 1); 4.2 mol/L CsA (lane (lane 3); 10 mol/L PD plus 4.2 mol/L CsA (lane 4); 10 mol/L SB
2); 10 mol/L PD (lane 3); 10 mol/L PD plus 4.2 mol/L CsA (lane (lane 5); 10 mol/L SB plus 4.2 mol/L CsA (lane 6); 10 mol/L PD
4); 10 mol/L SB (lane 5); 10 mol/L SB plus 4.2 mol/L CsA (lane 6); plus 10 mol/L SB (lane 7); and 10 mol/L PD plus 10 mol/L SB plus
10 mol/L PD plus 10 mol/L SB (lane 7); and 10 mol/L PD plus 10 4.2 mol/L CsA (lane 8).
mol/L SB plus 4.2 mol/L CsA (lane 8).
[29] demonstrated that MEK-mediated mechanisms are
was further supported by the finding that CsA increased required to assemble functional tight junctions in intesti-
the phosphorylation/activation of ERK 1/2. Furthermore, nal epithelial cells. They demonstrated that the interleu-
PD98059 prevented the CsA-induced phosphorylation/ kin (IL)–mediated increase in TER across T84 epithelial
activation of ERK 1/2 and reduced the CsA-mediated cells was blocked by PD98059. They also demonstrated
increase in TER. Addition of the p38 MAPK inhibitor that PD98059 decreased the basal TER of T84 monolayers.
also increased phosphorylation of ERK 1/2, which was However, other studies with genetically modified MDCK
most noticeable in the presence of CsA. The same combi- cells are less clear-cut in interpreting the possible role
nation of SB203580 and CsA also resulted in increased of the ERK 1/2 pathway in paracellular permeability.
TER compared to CsA alone, which provides further Potempa and Ridley [24] reported that in MDCK cells
evidence that activation/phosphorylation of ERK 1/2 is both hepatocyte growth factor (HGF)/scatter factor (SF)
involved in the CsA-mediated increase in TER. A direct and V12Ras disrupt the adherens junctions. The MEK 1
involvement of the p38 MAPK pathway was not evident inhibitor, PD98059, and the phosphatidylinositol (PI)
from these studies. However, some cross talk between 3-kinase inhibitor, LY294002, blocked this loss of adher-
the p38 and ERK 1/2 pathways appeared to be responsi- ens junctions. Chen, Schneeberger, and Goodenough [26]
ble for the increased phosphorylation of ERK 1/2 and in- demonstrated that after inhibition of the MAPK path-
creased TER detected in the presence of SB203580 and way, Ras-transformed MDCK cells changed their mor-
CsA. This possibility is further supported by the finding phology from an overlapping, fibroblastic-like phenotype
that the SB203580-induced increase in phosphorylation back to an epithelial cell monolayer. There was an ap-
in ERK 1/2 was prevented by the addition of PD98059. pearance of freeze fractured tight junction strands and
Several other studies implicate a role for the ERK 1/2 an almost fourfold increase in the TER. Thus, the Ras-
pathway in paracellular permeability but findings are Raf-MEK-ERK signaling pathway may regulate cell-
conflicting. Woo et al [28] found that the dexamethasone- cell junctions in a tissue type– and cell differentiation–
induced increase in TER across Con8 mammary cells was specific manner.
The current consensus of CsA immunosuppressive ac-reduced by PD98059. A recent study by Kinugasa et al
Kiely et al: MAPK and CsA-induced modulation of tight junction permeability 915
5. Ojakian GK: Tumor promoter-induced changes in the permeabil-tion is that CsA modulates intracellular actions via inhib-
ity of epithelial cell tight junctions. Cell 23:95–103, 1981
iting calcineurin. The ability of CsA to induce the ERK 6. Stenson WF, Easom RA, Riehl TE, Turk J: Regulation of paracel-
lular permeability in Caco-2 cell monolayers by protein kinase C.1/2 pathway raises the question as to whether this effect is
Am J Physiol 265:G955–G962, 1993dependent on the well-documented inhibitory action of
7. Canfield PE, Geerdes AM, Molitoris BA: Effect of reversible
CsA on calcineurin phosphatase. Use of CsA analogs sug- ATP depletion on tight-junction integrity in LLC-PK1 cells. Am J
Physiol 261:F1038–F1045, 1991gested that activation of MAPKs by CsA is not depen-
8. Gorodeski GI, Peterson DE, De Santis BJ, Hopfer U: Nucleotidedent on inhibition of calcineurin [17]. The analogs, which
receptor-mediated decrease of tight-junctional permeability in cul-
were tested, were CsA1MeAla-6 and CsA2MeBm2t. They tured human cervical epithelium. Am J Physiol 270:C1715–C1725,
1996both induced MAPK in HeLa cells in a manner similar
9. Moore R, Pothoulakis C, LaMont JT, et al: C. difficile toxin Ato CsA. CsA1MeAla-6 binds efficiently to cyclophilins increases intestinal permeability and induces Cl secretion. Am J
and inhibits their peptidyl-prolyl cis-trans isomerization Physiol 259:G165–G172, 1990
10. Lindmark T, Kimura Y, Artursson P: Absorption enhancement(PPIase) activity but has no immunosuppressive action.
through intracellular regulation of tight junction permeability byCsA2MeBm2t is immunosuppressive but has no inhibi- medium chain fatty acids in CACO-2 cells. J Pharmacol Experi-
tory effect on the PPIase activity of cyclophilins [38, 17]. mental Ther 284:362–369, 1998
11. Bennett WM, DeMattos A, Meyer MM, et al: Chronic cyclospo-Our findings demonstrate that CsA activated the ERK
rine nephropathy: the Achilles’ heel of immunosuppressive ther-
1/2 pathway in MDCK cells. Inhibition of this pathway apy. Kidney Int 50:1089–1100, 1996
12. Mihatsch MJ, Ryffel B, Hermle M, et al: Morphology of cyclospo-using PD98059 prevented the CsA-induced activation of
rine nephrotoxicity the rat. Clin Nephrol 25(Suppl 1):S2–S8, 1986ERK 1/2 and also prevented the CsA-induced increase in
13. Fasel J, Kaissling B, Ludwig KS, et al: Light and electron micro-
the TER. These results indicate that CsA may decrease scopic changes in the kidney of Wistar rats following treatment
with cyclosporine A. Ultrastruct Pathol 11:435–448, 1987paracellular permeability by activating the ERK 1/2
14. Whiting PH, Thomson AW, Simpson JG: Cyclosporine: toxicity,MAPK pathway.
metabolism, and drug interactions–implications from animal stud-
The time scale of changes detected in our laboratory ies. Transplant Proc 17(4 Suppl 1): S134–S144, 1985
15. Healy E, Dempsey M, Lally C, Ryan MP: Apoptosis and necrosis:in ERK 1/2 phosphorylation within minutes following
Mechanisms of cell death induced by cyclosporine A in a renalCsA treatment would indicate that the changes in proximal tubular cell line. Kidney Int 54:1955–1966, 1998
ERK1/2 phosphorylation are not due to changes in TER. 16. Clipstone NA, Crabtree GR: Identification of calcineurin as a key
signalling enzyme in T-lymphocyte activation. Nature 357:695–697,The changes in TER required a time period of 24 hours.
1992Taken together with our previous findings of CsA-induced 17. Paslaru L, Trigon S, Kuhlmann M, Morange M: MAP kinase
expression/phosphorylation of occludin and synergy with activation by cyclosporine A. Biochem Biophys Res Comm 236:
599–603, 1997the serine/threonine phosphatase inhibitor okadaic acid,
18. Cano E, Mahadevan LC: Parallel signal processing among mam-
these results strongly suggest that activation of the ERK malian MAPKs. TiBS 20:117–122, 1995
19. Su B, Karin M: Mitogen-activated protein kinase cascades and1/2 MAPK pathway is involved in the regulation of para-
regulation of gene expression. Curr Opin Immunol 8:402–411, 1996cellular permeability in our model and mediates the CsA-
20. Maruta H, Burgess AW: Regulation of the Ras signalling net-
induced increase in TER. work. Bioessays 16:489–496, 1994
21. Paul A, Wilson S, Belham CM, et al: Stress activated protein
kinases: Activation, regulation and function. Cell Signal 9:403–410,ACKNOWLEDGMENTS
1997
22. Dudley DT, Pang L, Decker SJ, et al: A synthetic inhibitor ofThis work was supported by Enterprise Ireland (the Irish Science
the mitogen-activated protein kinase cascade. Proc Natl Acad Sciand Technology Agency). Part of this work was presented at a meeting
USA 92:7686–7689, 1995of the British Pharmacological Society in Dublin, Ireland, July 2001.
23. Cuenda A, Rouse J, Doza YN, et al: SB 203580 is a specific
inhibitor of a MAP kinase homologue which is stimulated by cellu-Reprint requests to Professor Michael P. Ryan, Ph.D., Department
lar stresses and interleukin-1. FEBS Lett 364:229–233, 1995of Pharmacology, Conway Institute of Biomolecular and Biomedical
24. Potempa S, Ridley AJ: Activation of both MAP kinase and phos-Research, University College Dublin, Belfield, Dublin 4, Ireland.
phatidylinositide 3-kinase by Ras is required for hepatocyte growthEmail: michael.p.ryan@ucd.ie
factor/scatter factor-induced adherens junction disassembly. Mol
Biol Cell 9:2185–2200, 1998
25. Lu Q, Paredes M, Zhang J, Kosik KS: Basal extracellular signal-REFERENCES
regulated kinase activity modulates cell-cell and cell-matrix inter-
1. Marano CW, Lewis SA, Garulacan LA, et al: Tumor necrosis actions. Mol Cel Biol 18:3257–3265, 1998
factor-
 increases sodium and chloride conductance across the 26. Chen Y-H, Lu Q, Schneeberger EE, Goodenough DA: Restora-
tight junction of Caco-2 BBE, a human intestinal epithelial cell tion of tight junction structure and barrier function by down-regula-
line. J Membr Biol 161:263–274, 1998 tion of the mitogen-activated protein kinase pathway in Ras-trans-
2. Mullin JM, Snock KV: Effect of tumor necrosis factor on epithe- formed Madin-Darby canine kidney cells. Mol Biol Cell 11:849–862,
lial tight junctions and transepithelial permeability. Cancer Res 2000
50:2172–2176, 1990 27. Li D, Mrsny RJ: Oncogenic Raf-1 disrupts epithelial tight junctions
3. Cereijido M, Robbins ES, Dolan WJ, et al: Polarised monolayers via downregulation of occludin. J Cell Biol 148:791–800, 2000
formed by epithelial cells on a permeable and translucent support. 28. Woo PL, Ching D, Guan Y, Firestone GL: Requirement for Ras
J Cell Biol 77:853–879, 1978 and phosphatidylinositol 3-kinase signaling uncouples the gluco-
4. Tai Y-H, Flick J, Levine SA, et al: Regulation of tight junction corticoid-induced junctional organization and transepithelial elec-
resistance in T84 monolayers by elevation in intracellular Ca2: A trical resistance in mammary tumor cells. J Biol Chem 274:32818–
32828, 1999protein kinase C effect. J Membr Biol 149:71–79, 1996
Kiely et al: MAPK and CsA-induced modulation of tight junction permeability916
29. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC: Claudins regu- 34. Klintmalm GBG, Iwatsuki S, Startzl TE: Cyclosporine A hepa-
totoxicity in 66 renal allograft recipients. Transplantation 32:488–late the intestinal barrier in response to immune mediators. Gastro-
489, 1981enterology 118:1001–1011, 2000
35. Calne RY, White DJG, Thiru S, et al: Cyclosporine A in patients30. Madin SH, Darby NB: Established kidney cell lines of normal
receiving renal allografts from cadaver donors. Lancet 2:1323–1326,adult bovine and ovine origin. Proc Soc Exp Biol Med 98:574–576,
19781958
36. Lora L, Mazzon E, Billington D, et al: Effects of cyclosporin31. Borenfreund E, Puerner JA: A simple quantitative procedure
A on paracellular and transcellular transport of horseradish peroxi-using monolayer cultures for cytotoxicity assays (HTD/NR-90). J dase in perfused rat livers. Dig Dis Sci 42:514–521, 1997
Tissue Culture Methods 91:7–9, 1984 37. Roman ID, Coleman R: Disruption of canalicular function in iso-
32. Laemmli UK: Cleavage of structural proteins during the assembly lated rat hepatocyte couplets caused by cyclosporin A. Biochem
of the head of bacteriophage T4. Nature 227:680–685, 1970 Pharmacol 48:2181–2188, 1994
33. Reuss L: Tight junction permeability to ions and water, in Tight 38. Sigal NH, Dumont F, Durette P, et al: Is cyclophilin involved in
Junctions, edited by Cerijido M, Boca Raton, CRC Press, 1992, the immunosuppressive and nephrotoxic mechanism of action of
cyclosporin A? J Exp Med 173:619–628, 1991pp 49–66
